Syphilis co-infection does not affect HIV disease progression

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• HIV and syphilis share transmission routes, leading to frequent co-infections.
• Syphilis episodes cause transient decreases in CD4 counts and increases in HIV viral load.
• The long-term impact of syphilis co-infection on HIV disease progression remains uncertain.

Purpose of the Study:

• To investigate the effect of syphilis co-infection on the progression of HIV disease.
• To determine if syphilis impacts the time to acquired immunodeficiency syndrome (AIDS) or death in individuals with HIV.

Main Methods:

• Prospective analysis of 2239 individuals with estimated HIV seroconversion dates.
• Inclusion of confirmed and probable syphilis cases (total 9.2% and 2.9% respectively).
• Multivariate models adjusted for CD4 count, age, race, gender, and hepatitis B/C status, censored at HAART initiation or last visit.

Main Results:

• Syphilis co-infection was not associated with an increased hazard of AIDS or death (HR 0.99, 95% CI 0.73-1.33).
• Sensitivity analyses, including treating HAART as a time-varying covariate or limiting to confirmed syphilis, did not alter the primary findings.
• Transient changes in CD4 counts and viral loads during syphilis episodes did not translate to long-term disease progression differences.

Conclusions:

• Syphilis co-infection does not appear to accelerate HIV disease progression to AIDS or death.
• Despite temporary immunological fluctuations, syphilis does not significantly affect the long-term clinical course of HIV.
• These findings suggest that managing syphilis in HIV-positive individuals may not alter overall HIV disease trajectory.